Changes in exhaled breath particles lipid composition following experimental endotoxin challenge

O. Holz (Hannover, Germany), P. Larsson (Gothenburg , Sweden), H. Biller (Hannover, Germany), G. Koster (Southampton, United Kingdom), A. Postle (Southampton, United Kingdom), A. Olin (Gothenburg , Sweden), J. Hohlfeld (Hannover, Germany)

Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Session: Lung function tests and exhaled biomarkers
Session type: E-poster session
Number: 142
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Holz (Hannover, Germany), P. Larsson (Gothenburg , Sweden), H. Biller (Hannover, Germany), G. Koster (Southampton, United Kingdom), A. Postle (Southampton, United Kingdom), A. Olin (Gothenburg , Sweden), J. Hohlfeld (Hannover, Germany). Changes in exhaled breath particles lipid composition following experimental endotoxin challenge. 142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantification of inflammatory cytokines in exhaled breath particles following segmental and inhalation endotoxin challenge of healthy volunteers
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Year: 2021



Measurement of surfactant phospholipids in exhaled breath condensate
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Does human exposure to carbon particles and sulphur dioxide produce adverse changes in markers of inflammation in exhaled breath condensate, nasal lavage or serum?
Source: Eur Respir J 2004; 24: Suppl. 48, 604s
Year: 2004

Monitoring airway inflammation after allergen challenge by measuring 8-isoprostane in exhaled breath condensate
Source: Annual Congress 2010 - Biomarkers and diagnosis of allergic inflammatory diseases
Year: 2010

Exhaled breath condensate (EBC): changes in magnesium, pH and conductivity after exposure to swine house dust or inhaled LPS
Source: Eur Respir J 2005; 26: Suppl. 49, 734s
Year: 2005

Effects of concentrated ambient air particles (CAPs) on markers of airways inflammation in exhaled breath condensate of healthy volunteers
Source: Eur Respir J 2004; 24: Suppl. 48, 237s
Year: 2004

Changes of intermediate substrates of carbohydrate metabolism in exhaled breath condensate (EBC) during COPD development
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005

Welding fumes change the lipid composition of particles in exhaled air.
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018

Effect of varying respiratory pattern on exhaled breath condensate collection
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Changes in exhaled breath condensate pH following specific inhalation challenge in patients with occupational asthma to persulfate salts
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011

The changes of nitric oxide metabolism and soluble forms of differentiated antigens levels in exhaled breath condensate (EBC) in Chernobyl clean-up workers with COPD
Source: Annual Congress 2009 - Occupational exposures and disease II
Year: 2009

Biomarkers of oxidative stress in exhaled breath condensate following ozone exposure in volunteers
Source: Eur Respir J 2001; 18: Suppl. 33, 460s
Year: 2001

Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Validation of eicosanoid measurements in exhaled breath condensate
Source: Eur Respir J 2002; 20: Suppl. 38, 422s
Year: 2002

Airway cytokine expression measured by protein array in exhaled breath condensate: correlation with physiological properties in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

A new approach for exhaled breath condensate analysis by calculating the release of mediators per minute, standardised for the total water vapour in exhaled air
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010

TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls
Source: Eur Respir J 2012; 39: 59-66
Year: 2012



TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls
Source: Eur Respir J 2011; 39: 59-66
Year: 2012



Dynamics of lipid peroxidation products in exhaled breath condensate in asthmatics in response to dosed physical exercise
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016


Study on the origin and collection of exogenous compounds in exhaled breath aerosol particles
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015